Even as drug makers promise to support Washington’s health care overhaul by shaving $8 billion a year off the nation’s drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years.
Enlarge This Image
Allen Brisson-Smith for The New York Times
Stephen W. Schondelmeyer, a pharmaceutical economics professor at the University of Minnesota, said, “When we have major legislation anticipated, we see a run-up in price increases.”
HEALTH CARE CONVERSATIONS
What do you think of drug companies raising prices in the run-up to health care legislation?
Join this Discussion
Share your thoughts about the health care debate
A blog from The New York Times that tracks the health care debate as it unfolds.
More Health Care Overhaul News
Multimedia
Graphic
Charging More for Prescription Drugs
Add to Portfolio
Merck & Company Inc
Go to your Portfolio »
In the last year, the industry has raised the wholesale prices of brand-name prescription drugs by about 9 percent, according to industry analysts. That will add more than $10 billion to the nation’s drug bill, which is on track to exceed $300 billion this year. By at least one analysis, it is the highest annual rate of inflation for drug prices since 1992.
The drug trend is distinctly at odds with the direction of the Consumer Price Index, which has fallen by 1.3 percent in the last year.
http://www.nytimes.com/2009/11/16/business/16drugprices.html?hpIs there anyone who couldn't have seen this coming? Raising their prices 10% to offset the 8% they have promised to put back on the table for Medicare part D?